SCHEMBL6963796

SCHEMBL6963796

Fc1ccc(-c2c[nH]c(CCCN3CCOCC3)c2-c2ccncc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 9/20 0.51
MAPK13 O15264 7/20 0.51
MAPK12 P53778 7/20 0.51
MAPK11 Q15759 7/20 0.51
NFATC1 O95644 1/20 0.43
GSK3B P49841 1/20 0.43
DYRK1A Q13627 1/20 0.43
ALOX5 P09917 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
KDM4E B2RXH2 1/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6962798 0.79 MAPK14 (0.47) MAPK14MAPK13MAPK12MAPK11
SCHEMBL6953493 0.75 MAPK14 (0.64) MAPK14MAPK13MAPK12MAPK11
SCHEMBL6246309 0.74 MAPK14 (0.50) MAPK14MAPK13MAPK12MAPK11
SCHEMBL5443213 0.73 MAPK14 (0.49) MAPK14MAPK13MAPK12MAPK11ALOX5
SCHEMBL4585385 0.72 ALOX5 (0.62) MAPK14MAPK13MAPK12MAPK11GSK3B
SCHEMBL14519484 0.72 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11ALOX5
SCHEMBL5255744 0.72 MAPK14 (0.58) MAPK14MAPK13MAPK12MAPK11NFATC1
SCHEMBL6077643 0.72 MAPK14 (0.58) MAPK14MAPK13MAPK12MAPK11NFATC1
SCHEMBL6219428 0.71 MAPK14 (0.48) MAPK14MAPK13MAPK12MAPK11TSHR
SCHEMBL6963552 0.71 MAPK14 (0.39) MAPK14MAPK13MAPK12MAPK11ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1178981-B1 SUBSTITUTED 3-PYRIDYL-4-ARYLPYRROLES, AND RELATED THERAPEUTIC AND PROPHYLACTIC METHODS ORTHO MCNEIL PHARM INC (US) 2003-06-25 EP disclosed
US-6562843-B1 For treating disorders ameliorated by a reduction in TNF-alpha production and/or p38 activity, and are therefore useful for treating inflammatory disorders such as rheumatoid arthritis, as well as AIDS-related disorders ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-05-13 US disclosed
EP-1178981-A1 SUBSTITUTED 3-PYRIDYL-4-ARYLPYRROLES, AND RELATED THERAPEUTIC AND PROPHYLACTIC METHODS Ortho-Mcneil Pharmaceutical, Inc. (US) 2002-02-13 EP disclosed
WO-2000069847-A1 SUBSTITUTED 3-PYRIDYL-4-ARYLPYRROLES, AND RELATED THERAPEUTIC AND PROPHYLACTIC METHODS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2000-11-23 WO disclosed